Abstract

Correction to: European Review for Medical and Pharmacological Sciences 2019; 23 (18): 7802-7807-DOI: 10.26355/eurrev_201909_18989-PMID: 31599404, published online 15 September, 2020. The authors state that "to compare the results with those of bladder cancer in the literature we reported the study by Li D, Song L, Wen Z, Li X, Jie J, Wang Y, Peng L. Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis- eQTL locus contributing more to the susceptibility of lung cancer. Oncotarget 2016; 7: 35813-35817. In particular, we referred to their table format, but we misused the reference table as the official table in the manuscript". In addition to Table I, the authors make the following corrections: • in the abstract results change "(OR: 1.33; 95% CI: 1.09-1.61; p = 0.004)" to "(OR: 1.31; 95% CI: 1.08-1.6; p=0.007)." • in the "Association of tagSNPs of the Cis-eQTL for ZNRD1 in ZNRD1-AS1 Gene Region With EC Susceptibility" paragraph change "(OR: 1.33; 95% CI: 1.09-1.61; p = 0.004)" to "(OR: 1.31; 95% CI: 1.08-1.6; p=0.007), "1.71 (95% CI: 1.11-2.64)" to "1.67 (95% CI: 1.07-2.59)", and "(0.004 × 3 = 0.012 < 0.05)" to "(0.007*3=0.021<0.05)". There are amendements to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18989.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call